Post Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators
Post Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb and the Cancer Research Institute Announce Collaboration to Accelerate Immuno-Oncology Research
Post James Allison, Parker Institute for Cancer Immunotherapy Director, Wins 2018 Nobel Prize in Medicine or Physiology for Research on Immune Checkpoint Inhibitors
Post Parker Institute for Cancer Immunotherapy Researchers Present Findings on Pancreatic Cancer, Tumor Vaccines and CAR-T at 2017 Society for Immunotherapy of Cancer Annual Meeting
Post Empowering Tomorrow’s Great Minds in Cancer Research: The Parker Institute for Cancer Immunotherapy Awards up to $4.5 Million to Nine Early Career Researchers